Skip to Content

NDT Pharmaceuticals Inc NDTP

Morningstar Rating
$0.05 −0.08 (60.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NDTP is trading at a 64% discount.
Price
$0.05
Fair Value
$5.32
Uncertainty
Extreme
1-Star Price
$2.66
5-Star Price
$3.52
Economic Moat
Tth
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NDTP is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.13
Day Range
$0.050.05
52-Week Range
$0.001.00
Bid/Ask
$0.06 / $0.20
Market Cap
$56,250.00
Volume/Avg
200 / 5,406

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

NDT Pharmaceuticals Inc is a biotechnology company focused on developing revolutionary therapies for severe neurological disorders associated with traumatic brain injury. Its Nanoscale Particle Complex (NPC) technology represents the leading edge of phospholipid-based nano-encapsulation delivery systems (less than 100 nanometers in diameter; mean diameter of 40 nanometers in current liquid product samples with the capability to engineer significantly smaller nanocarrier particles) that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees

Valuation

Metric
NDTP
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NDTP
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
NDTP
Return on Assets (Normalized)
−8.11%
Return on Equity (Normalized)
−13.21%
Return on Invested Capital (Normalized)
−8.70%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRNlps$550.2 Bil
VRTX
Vertex Pharmaceuticals IncMzhpzg$111.1 Bil
REGN
Regeneron Pharmaceuticals IncNzmfwg$107.7 Bil
MRNA
Moderna IncGwws$36.9 Bil
ARGX
argenx SE ADRPtft$24.2 Bil
BNTX
BioNTech SE ADRMpsh$22.3 Bil
ALNY
Alnylam Pharmaceuticals IncPptglk$19.9 Bil
BMRN
Biomarin Pharmaceutical IncXbkcnt$17.2 Bil
RPRX
Royalty Pharma PLC Class AThrbgm$13.9 Bil
INCY
Incyte CorpQpgdpc$13.6 Bil

Sponsor Center